Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...
A retired British couple said their £5,000 dream cruise turned into an “absolute disaster” after they were confined to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results